| scholarly article | Q13442814 |
| P2093 | author name string | H Lin | |
| X Chen | |||
| T Sano | |||
| K R Hess | |||
| W K Yung | |||
| Y K Hong | |||
| L A Langford | |||
| M L Bondy | |||
| J N Myers | |||
| P A Steck | |||
| D Koul | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 1820-1824 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis | |
| P478 | volume | 59 |
| Q50936345 | Assessment of genetic markers and glioblastoma stem-like cells in activation of dendritic cells. |
| Q48712580 | Biologic tumor behavior in pilocytic astrocytomas |
| Q30481789 | Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium |
| Q24320241 | CSIG inhibits PTEN translation in replicative senescence |
| Q41912188 | Cardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes. |
| Q34549622 | Cerebral Gluconeogenesis and Diseases |
| Q35800526 | Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area |
| Q38304039 | Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration |
| Q36529884 | Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death |
| Q37438154 | Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis |
| Q34221722 | Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era. |
| Q38821975 | Down-regulation of ribosomal protein S15A inhibits proliferation of human glioblastoma cells in vivo and in vitro via AKT pathway |
| Q36411906 | Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis. |
| Q42160676 | Establishment of prognostic models for astrocytic and oligodendroglial brain tumors with standardized quantification of marker gene expression and clinical variables |
| Q37442718 | Estrogen partially down-regulates PTEN to prevent apoptosis in VSC4.1 motoneurons following exposure to IFN-gamma |
| Q38734366 | Evolving Molecular Genetics of Glioblastoma |
| Q34123951 | Expression of phosphatase and tensin homolog, epidermal growth factor receptor, and Ki-67 in astrocytoma: A prospective study in a tertiary care hospital |
| Q35842249 | Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas |
| Q39481837 | Gambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cells |
| Q48228104 | Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas |
| Q33727858 | High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism |
| Q38980829 | Identification of nucleolus-localized PTEN and its function in regulating ribosome biogenesis |
| Q55473298 | Immunohistochemical markers for prognosis of anaplastic astrocytomas. |
| Q48505519 | Immunohistochemical markers for prognosis of cerebral glioblastomas |
| Q36178164 | Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer |
| Q36648105 | Incidence, mechanism and prognostic value of activated AKT in pancreas cancer |
| Q48585558 | Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas |
| Q35880328 | Insulin-like growth factor binding protein 2 promotes glioma development and progression |
| Q30437740 | Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy |
| Q51731819 | Investigation of MMAC/PTEN gene mutations and protein expression in low grade gliomas |
| Q42413905 | Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma |
| Q27851755 | Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era. |
| Q34382719 | Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions |
| Q42013793 | Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma |
| Q37594101 | MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A. |
| Q37917655 | MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas |
| Q35800128 | Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables |
| Q92906114 | Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions |
| Q92207064 | Myosin 1b Regulates Nuclear AKT Activation by Preventing Localization of PTEN in the Nucleus |
| Q34996130 | Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field |
| Q42218359 | Nongenomic Mechanisms of PTEN Regulation |
| Q37176193 | Nuclear and mitochondrial signalling Akts in cardiomyocytes |
| Q90176934 | OSgbm: An Online Consensus Survival Analysis Web Server for Glioblastoma |
| Q47131994 | PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database. |
| Q35691011 | PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer |
| Q92316075 | PTEN Tumor-Suppressor: The Dam of Stemness in Cancer |
| Q37254063 | PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis |
| Q24528114 | PTEN function: how normal cells control it and tumour cells lose it |
| Q44702044 | PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus |
| Q35746631 | PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis |
| Q37856722 | PTEN loss in the continuum of common cancers, rare syndromes and mouse models. |
| Q37620711 | PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons. |
| Q39615005 | PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts |
| Q50977901 | PTEN, Longevity and Age-Related Diseases |
| Q35865773 | Pathology and molecular genetics of astrocytic gliomas |
| Q45006311 | Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs. |
| Q46410598 | Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. |
| Q33710967 | Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma |
| Q48520102 | Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas |
| Q35619493 | Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy |
| Q34117879 | RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells |
| Q36643707 | Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1. |
| Q41492330 | Relationship between expression and prognostic ability of PTEN, STAT3 and VEGF-C in colorectal cancer |
| Q24657979 | Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cells |
| Q33502757 | Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons |
| Q42067411 | Standardization of Gene Expression Quantification by Absolute Real-Time qRT-PCR System Using a Single Standard for Marker and Reference Genes |
| Q37872655 | Targeting phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs |
| Q26778641 | The associations between Parkinson's disease and cancer: the plot thickens |
| Q43236003 | The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients |
| Q48261432 | The importance of genomic copy number changes in the prognosis of glioblastoma multiforme |
| Q57162865 | The p53 Pathway in Glioblastoma |
| Q41440571 | Therapeutic strategies for spinal muscular atrophy: SMN and beyond. |
| Q46809466 | Tyrosine kinase expression in pediatric high grade astrocytoma |
| Q38411723 | Whole Genome Analysis From Microdissected Tissue Revealed Adult Supratentorial Grade II-III Gliomas Are Divided Into Clinically Relevant Subgroups by Genetic Profile |
| Q40407116 | mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma |
| Q36742601 | miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study |
Search more.